Company: BSTZ
Filing Date: 2025-03-07
Form Type: N-CSR
Source: 0001193125-25-049659
Chunk: 21

Company: BlackRock Science & Technology Term Trust
Filing Date: 2025-03-07
Form: N-CSR
Chunk 21
---
 1 Year | SinceInception(a) |
| Trust at NAV(b)(c)                                      |                        2.11% |             4.41% |
| Trust at Market Price(b)(c)                             |                         9.40 |              1.64 |
| MSCI Custom ACWI SMID Growth HC Call Overwrite Index(d) |                         1.32 |             -3.97 |
| MSCI ACWI                                               |                        17.49 |             10.22 |

| (a) | BMEZ commenced operations on January 30, 2020.                                                                                                                                                                                                                             |
|:----|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (b) | All returns reflect reinvestment of dividends and/or distributions at actual reinvestment prices.                                                                                                                                                                          |
| (c) | TheTrust’s discount to NAV narrowed during the period, which accounts for the difference between performance based on market price and performance based on NAV.                                                                                                           |
| (d) | An index representing the Health Care sector stocks within the MSCI ACWI SMID Cap Growth Index and incorporating an option overlay component with a 25% overwrite                                                                                                          
 level. TheMSCI ACWI SMID Cap Growth Index captures mid- and small-cap                                                                                                                                                                                                      
 securities exhibiting overall growth style characteristics across certain developed and emerging markets countries.The index commenced on March 31, 2022 and therefore the since inception return presented is for the period March 31, 2022 through the current reporting 
 period.                                                                                                                                                                                                                                                                    |

Performance results may include adjustments made for financial reporting purposes in accordance with U.S. generally accepted accounting principles.
Past performance is not an indication of future results. The Trust is presenting the performance of one or more indices for informational purposes only. The Trust is actively managed and does not seek to track or replicate the performance of any index. The index performance shown is not intended to be indicative of the Trust’s investment strategies, portfolio components or past or future performance. More information about the Trust’s historical performance can be found in the “Closed End Funds” section of blackrock.com . The following discussion relates to the Trust’s relative performance based on NAV: What factors influenced performance? At the sector level, an underweight allocation to healthcare providers and services and security selection in pharmaceuticals contributed to relative performance. An out-of-benchmark position in Intuitive Surgical, Inc. was the leading contributor among the Trust’s individual holdings. The company experienced strong growth in the installations and procedural volumes for its da Vinci surgical robotic